Does TREPROSTINIL Cause Device occlusion? 458 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 458 reports of Device occlusion have been filed in association with TREPROSTINIL (TYVASO). This represents 0.5% of all adverse event reports for TREPROSTINIL.
458
Reports of Device occlusion with TREPROSTINIL
0.5%
of all TREPROSTINIL reports
20
Deaths
211
Hospitalizations
How Dangerous Is Device occlusion From TREPROSTINIL?
Of the 458 reports, 20 (4.4%) resulted in death, 211 (46.1%) required hospitalization, and 10 (2.2%) were considered life-threatening.
Is Device occlusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 458 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Device occlusion?
PEGFILGRASTIM (3,239)
CARBIDOPA\LEVODOPA (1,464)
SOMATROPIN (823)
LEUPROLIDE (786)
EPOPROSTENOL (580)
ALBUTEROL (431)
MEDROXYPROGESTERONE (284)
BACLOFEN (254)
LEVODOPA (224)
RISPERIDONE (182)
Which TREPROSTINIL Alternatives Have Lower Device occlusion Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE